For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Part 1A Cohort 2A | Trame 1 mg Cont | 2 | None | 0 | 3 | 3 | 3 | View |
| Part 1A Cohort 3 | Trame 1.5 mg Int | 3 | None | 2 | 3 | 3 | 3 | View |
| Part 1A Cohort 3B | Trame 2 mg Int | 5 | None | 3 | 7 | 7 | 7 | View |
| Part 1B | Nivo 6 + Ipi 1 + Trame 1.5 | 49 | None | 42 | 82 | 82 | 82 | View |
| Part 2 Treatment 1 | Nivo 6 + Ipi 1 + Trame 1.5 | 108 | None | 79 | 121 | 121 | 121 | View |
| Part 2 Treatment 2 | Regorafenib 80/160 | 55 | None | 33 | 57 | 55 | 57 | View |
| Part 1 Cohort 1D | Trame 2 mg Cont | 6 | None | 5 | 6 | 6 | 6 | View |
| Part 1A Cohort 2 | Trame 1.5 mg Cont | 3 | None | 3 | 7 | 7 | 7 | View |
| Part 1 Cohort 1 | Trame 1.5 mg Cont | 2 | None | 2 | 3 | 3 | 3 | View |
| Part 1 Cohort 1B | Trame 2 mg Int | 2 | None | 0 | 3 | 3 | 3 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hypothyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 27.1 | View |
| Cardiac failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Cardiac failure congestive | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Sinus tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Adrenal insufficiency | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 27.1 | View |
| Anaemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 27.1 | View |
| Atrial fibrillation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Cardiac arrest | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Detachment of retinal pigment epithelium | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Eyelid ptosis | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Abdominal distension | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Anal fistula | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Ascites | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Duodenal ulcer | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Enteritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Gastrointestinal haemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Gastrooesophageal haemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Haematochezia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Ileus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Immune-mediated enterocolitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Intestinal ischaemia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Intestinal obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Intestinal perforation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Intestinal pseudo-obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Large intestinal obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Pancreatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Rectal haemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Rectal perforation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Small intestinal obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Stomatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Asthenia | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Cardiac death | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Disease progression | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Influenza like illness | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Localised oedema | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Non-cardiac chest pain | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Oedema peripheral | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Acute cholecystitis necrotic | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Acute hepatic failure | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Biliary cast syndrome | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Biliary obstruction | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Cholangitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Drug-induced liver injury | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Hepatic failure | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Hepatic function abnormal | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Hepatitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Hyperbilirubinaemia | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Hypertransaminasaemia | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Immune-mediated hepatitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Jaundice | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Jaundice cholestatic | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Liver disorder | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Malignant biliary obstruction | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Bacteraemia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| COVID-19 | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Cellulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Clostridium difficile colitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Enterocolitis infectious | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Listeriosis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Pneumonia pneumococcal | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Proteus infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Septic shock | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Soft tissue infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Stoma site abscess | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Stoma site infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Streptococcal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Upper respiratory tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Urosepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Vascular device infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Hip fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 27.1 | View |
| Infusion related reaction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 27.1 | View |
| Intentional overdose | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 27.1 | View |
| Limb injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 27.1 | View |
| Overdose | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 27.1 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Amylase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood bilirubin increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood lactic acid increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Ejection fraction decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Gamma-glutamyltransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Decreased appetite | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Diabetic ketoacidosis | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hyperkalaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hypokalaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hyponatraemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Type 1 diabetes mellitus | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Brain neoplasm malignant | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 27.1 | View |
| Colorectal cancer | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 27.1 | View |
| Malignant neoplasm progression | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 27.1 | View |
| Metastases to central nervous system | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 27.1 | View |
| Metastases to eye | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 27.1 | View |
| Neoplasm malignant | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 27.1 | View |
| Neoplasm progression | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 27.1 | View |
| Tumour haemorrhage | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 27.1 | View |
| Cerebrovascular accident | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Hepatic encephalopathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Hyponatraemic encephalopathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Spinal cord compression | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Transient ischaemic attack | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Confusional state | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 27.1 | View |
| Delirium | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 27.1 | View |
| Mental status changes | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 27.1 | View |
| Acute kidney injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 27.1 | View |
| Hydronephrosis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 27.1 | View |
| Urinary tract obstruction | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 27.1 | View |
| Intermenstrual bleeding | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | 27.1 | View |
| Pelvic pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | 27.1 | View |
| Dyspnoea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Haemoptysis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Immune-mediated lung disease | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Pneumonitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Pulmonary embolism | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Drug eruption | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Erythrodermic psoriasis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Rash maculo-papular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Rash papular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Deep vein thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | 27.1 | View |
| Embolism | SYSTEMATIC_ASSESSMENT | Vascular disorders | 27.1 | View |
| Extrinsic iliac vein compression | SYSTEMATIC_ASSESSMENT | Vascular disorders | 27.1 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | 27.1 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Asthenia | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Chills | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Early satiety | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Gait disturbance | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Influenza like illness | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Malaise | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Mucosal inflammation | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Oedema peripheral | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Thirst | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Xerosis | SYSTEMATIC_ASSESSMENT | General disorders | 27.1 | View |
| Hyperbilirubinaemia | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| Hypertransaminasaemia | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | 27.1 | View |
| COVID-19 | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Candida infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Cellulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Gingivitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Mucosal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Paronychia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Rash pustular | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | 27.1 | View |
| Burns first degree | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 27.1 | View |
| Infusion related reaction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 27.1 | View |
| Thermal burn | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 27.1 | View |
| Activated partial thromboplastin time prolonged | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood albumin decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood alkaline phosphatase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood bilirubin increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood calcium decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood lactate dehydrogenase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood magnesium decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood phosphorus decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood potassium decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood sodium decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Blood thyroid stimulating hormone increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Ejection fraction decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Lymphocyte count decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Weight decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| White blood cell count decreased | SYSTEMATIC_ASSESSMENT | Investigations | 27.1 | View |
| Decreased appetite | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hyperglycaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hyperphosphataemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hypoalbuminaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hypocalcaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hypokalaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hypomagnesaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hyponatraemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hypophosphataemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Hypovolaemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 27.1 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Arthritis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Coccydynia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Productive cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Joint range of motion decreased | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Muscle spasms | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Musculoskeletal chest pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Flushing | SYSTEMATIC_ASSESSMENT | Vascular disorders | 27.1 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 27.1 | View |
| Cancer pain | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 27.1 | View |
| Cerebral ischaemia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Hot flush | SYSTEMATIC_ASSESSMENT | Vascular disorders | 27.1 | View |
| Disturbance in attention | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Dysgeusia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Dyskinesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Hypoaesthesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | 27.1 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | 27.1 | View |
| Vena cava thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | 27.1 | View |
| Peripheral motor neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Presyncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Taste disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 27.1 | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 27.1 | View |
| Confusional state | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 27.1 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 27.1 | View |
| Dysuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 27.1 | View |
| Haematuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 27.1 | View |
| Hydronephrosis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 27.1 | View |
| Proteinuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 27.1 | View |
| Pelvic pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | 27.1 | View |
| Vaginal haemorrhage | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | 27.1 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Dysphonia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Dyspnoea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Dyspnoea exertional | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Epistaxis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Hiccups | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Pneumonitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Pneumothorax | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Hyperthyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 27.1 | View |
| Hypothyroidism | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 27.1 | View |
| Diplopia | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Dry eye | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Iridocyclitis | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Ocular hyperaemia | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Retinopathy | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Subretinal fluid | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Swelling of eyelid | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Uveitis | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Vision blurred | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Visual impairment | SYSTEMATIC_ASSESSMENT | Eye disorders | 27.1 | View |
| Abdominal distension | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Abdominal pain upper | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Ascites | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Diarrhoea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Diarrhoea haemorrhagic | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Dyspepsia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Flatulence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Gingival bleeding | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Haematochezia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Large intestinal obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Proctalgia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Rectal haemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Small intestinal obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Stomatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 27.1 | View |
| Anaemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 27.1 | View |
| Increased tendency to bruise | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 27.1 | View |
| Neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 27.1 | View |
| Thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 27.1 | View |
| Cardiac disorder | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Palpitations | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Sinus bradycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Sinus tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 27.1 | View |
| Vertigo | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 27.1 | View |
| Pulmonary embolism | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Throat irritation | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 27.1 | View |
| Blister | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Dermatitis acneiform | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Drug eruption | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Dry skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Erythema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Hyperhidrosis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Palmar-plantar erythrodysaesthesia syndrome | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Photosensitivity reaction | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Pruritus allergic | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Rash erythematous | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Rash maculo-papular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Rash papular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Rash pruritic | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Skin fissures | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |
| Skin lesion | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 27.1 | View |